Presage Biosciences
Business Services · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
530 Fairview Ave N Ste 1000, Seattle, Wa...Phone Number
(800) 530-5404Website
www.presagebio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
2
1
1
1
1
About Presage Biosciences
Presage, founded in 2008 and headquartered in Seattle, Washington, develops technology that delivers microdoses of multiple drugs to different regions of a tumor, while the tumor is still in the patient.Explore more
Presage Biosciences Org Chart
JF
Vice President, Scientific Operations
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Presage Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Presage Biosciences launches new products
Click to see if Presage Biosciences had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Presage Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Presage Biosciences has new funding data
Congratulate Masked Content for being promoted to Masked Content at Presage Biosciences
Check if Presage Biosciences has recently received funding, and reach out quickly before it becomes old news!
Check out if Presage Biosciences is spiking on competitors!
Earning: See what the market has to say on Presage Biosciences recently announced quarterly report
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Presage Biosciences
Compare insights from companies similar to Presage Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Presage Biosciences
<$5M
11-50
Private
$13.7M
2008
JB
Jessica BertoutVice President, Acting, Alliance & Program Management
Company Profile Activity
Activity Insights
Presage Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Presage Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Presage Biosciences.
Presage Biosciences financials insights
Gather financial insights about Presage Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
2021
Multiple Rounds
$13.4M
Presage Biosciences Tech Stack
A closer look at the technologies used by Presage Biosciences
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Left Company
Executive Move
Executive Moves, Left Company
Funding
Funding
Presage Biosciences has received an SBA PPP loan in the amount of $365,160 from Silicon Valley Bank resulting in the retention of 17 jobs.
Funding
Presage Biosciences News & Media
Presage Biosciences Announces First Patient Dosing of Pure Biologics' ROR1 Targeting Antibody For Treatment of Cancer
SEATTLE, July 25, 2024 /PRNewswire/ -- Presage Biosciences, a biotechnology company that directly measures activity of oncology drugs within human tumors, announced the Phase 0 dosing of the first cancer patient with Pure Biologics' PBA-0405, an antibody that targets ROR1. PBA-0405 has...Presage Announces FDA Study May Proceed to Evaluate Pre-GMP Drug Candidate in CIVO Phase 0 Clinical Trial
SEATTLE, Jan. 16, 2024 /PRNewswire/ -- Presage Biosciences, a biotechnology company whose mission is to enable precision drug response evaluation in the human tumor microenvironment (TME), announced that the U.S. Food and Drug Administration (FDA) has issued a Study May Proceed...Presage Biosciences Announces New Pharma Partnership to Evaluate Novel Immuno-Oncology Drug Combinations with CIVO® Technology
SEATTLE, Nov. 30, 2023 /PRNewswire/ -- Presage Biosciences, a pioneering translational oncology company whose mission is to use CIVO and spatial molecular profiling to understand the complexity of drug response in the tumor microenvironment (TME), has entered into an agreement with...Presage to Present at AACR 2023 - Core CIVO Technology Reveals Unexpected Effects of an Investigational Ubiquitination Inhibitor on Checkpoint Blockade
SEATTLE, April 17, 2023 /PRNewswire/ -- Presage Biosciences, a pioneer in translational oncology whose mission is understanding the complexity of drug response in the tumor microenvironment (TME), will present at the Immunology, TME Minisymposium at the American Association for Cancer...
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Presage Biosciences
Sign Up For FreeTo access detailed company insights
Presage, founded in 2008 and headquartered in Seattle, Washington, develops technology that delivers microdoses of multiple drugs to different regions of a tumor, while the tumor is still in the patient.... Read More
